Is Cellectis SA CLLS stock halal to invest in?

No, as of February 2026, Cellectis SA stock (CLLS) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. Cellectis SA has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for Cellectis SA and alternative halal stock options within the Tabadulat app.

How often is Cellectis SA CLLS reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on Cellectis SA CLLS monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does Cellectis SA CLLS pass the AAOIFI Non Permissible Income criteria?

No, as of February 2026, Cellectis SA stock (CLLS) does not pass the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does Cellectis SA CLLS pass the AAOIFI Interest Bearing Investments criteria?

No, as of February 2026, Cellectis SA stock (CLLS) does not pass the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments have exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

No, as of February 2026, Cellectis SA stock (CLLS) does not pass the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

English

العربية

Be the First to Know!

Join our waitlist for exclusive early access to Tabadulat’s Shariah-compliant trading platform. Get notified as soon as we go live and start investing with confidence.

Cellectis SA

NASDAQ

Shariah-Compliant

Not Shariah

CLLS

About

Cellectis SA

CLLS

Cellectis S.A. - ADR represents American Depositary Receipts of the French biotechnology company Cellectis S.A. This company specializes in the development of gene-editing technologies, particularly focusing on allogeneic CAR-T cell therapies for the treatment of cancer. Cellectis utilizes its proprietary TALEN (Transcription Activator-Like Effector Nucleases) technology to precisely edit genes, aiming to harness the power of modified immune cells to target and destroy malignancies. Cellectis operates at the cutting edge of biotechnology, playing a pivotal role in the burgeoning field of personalized medicine and immunotherapy. Through partnerships with major pharmaceutical firms and research institutions, Cellectis aims to innovate and refine therapeutic approaches in the oncology sector. The ADRs allow U.S. investors to engage with Cellectis's pioneering activities without the complexities of foreign stock purchase, illustrating the company's commitment to broadening its investor base and support for global biomedical advances. In the financial market, Cellectis S.A. - ADR is significant due to its contributions towards breakthrough cancer therapies and its involvement in a rapidly developing segment of the healthcare industry.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

216

Website:

https://www.cellectis.com

CLLS

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

Cellectis SA

About

Cellectis SA

CLLS

Frequently asked questions

Is Cellectis SA CLLS stock halal to invest in?

How often is Cellectis SA CLLS reviewed for Shariah compliance?

Does Cellectis SA CLLS pass the AAOIFI Non Permissible Income criteria?

Does Cellectis SA CLLS pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy Cellectis SA CLLS stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.